Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1390, 2012-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs, Vol. 71, Iss. 10, 2011-07 ,pp. :
Access to resources
Recommend
Eribulin mesylate for the treatment of breast cancer
By Cigler Tessa Vahdat Linda T
Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. :
Letter warns of risk of fatal TRALI with blood product infusions
Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. :
MHRA advises product information update for antipsychotics
Reactions Weekly, Vol. 1, Iss. 1122, 2006-01 ,pp. :